Henry E. Pelish, Chief Scientific Officer at Nuvalent, Inc. (NUVL), sold 21,600 shares at $79.92 ($1.7M) on 2025-06-27, disclosed to the SEC on 2025-06-27.
Scheduled sale ($1.7M) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $79.87 | 8,630 | $689K | 39.9% |
| 2 | $79.87 | 8,630 | $689K | 39.9% |
| 3 | $79.92 | 2,170 | $173K | 10.1% |
| 4 | $79.92 | 2,170 | $173K | 10.1% |
| Total | $79.88 avg | 21,600 | $1.7M | 100% |
| Filing → |
| NUVL | SELL | 2026-03-16 | $3.4M | — | Filing → |
| NUVL | SELL | 2026-01-07 | $502K | — | Filing → |
| NUVL | SELL | 2025-10-17 | $2.6M | — | Filing → |